BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10176771)

  • 1. Mutual fund, charge card companies could emerge as competitors to HMOs.
    Campbell S
    Health Care Strateg Manage; 1997 Dec; 15(12):13. PubMed ID: 10176771
    [No Abstract]   [Full Text] [Related]  

  • 2. Competitive forces in the medical group industry: a stakeholder perspective.
    Blair JD; Buesseler JA
    Health Care Manage Rev; 1998; 23(2):7-27. PubMed ID: 9595307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The big money in Medicaid. A boom in HMOs for the neediest leads to litigation, controversy--and lots of profits.
    McLean B
    Fortune; 2007 Jun; 155(12):97-8, 100, 102. PubMed ID: 17639994
    [No Abstract]   [Full Text] [Related]  

  • 4. Does business really care what doctors think?
    Pretzer M
    Med Econ; 1999 Aug; 76(15):51-2, 55. PubMed ID: 10557819
    [No Abstract]   [Full Text] [Related]  

  • 5. Hospitals need to help Medicare HMOs.
    Johnson DE
    Health Care Strateg Manage; 1998 Sep; 16(9):2-3. PubMed ID: 10182997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beginning of the end for HMOs. Part 1: The awakening market.
    Beckham JD
    Healthc Forum J; 1997; 40(6):44-7. PubMed ID: 10175123
    [No Abstract]   [Full Text] [Related]  

  • 7. Marketplace. How the stock market fall hits health care firms.
    Moskowitz DB
    Faulkner Grays Med Health; 1997 Nov; 51(43):suppl 2 p.. PubMed ID: 10173708
    [No Abstract]   [Full Text] [Related]  

  • 8. Defining competition in markets: why and how?
    Bernstein AB; Gauthier AK
    Health Serv Res; 1998 Dec; 33(5 Pt 2):1421-38. PubMed ID: 9865227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do integrated systems need to own HMOs?
    Cochrane JD
    Integr Healthc Rep; 1998 Apr; ():1-6. PubMed ID: 10180265
    [No Abstract]   [Full Text] [Related]  

  • 10. Oh, the possibilities.... Understanding e-commerce to exercise its full potential.
    Fernandez F
    Mater Manag Health Care; 2002 Jan; 11(1):17-21. PubMed ID: 11828669
    [No Abstract]   [Full Text] [Related]  

  • 11. Stock experts are optimistic about future of public HMOs.
    Greenwald J
    Bus Insur; 1985 Nov; 19(45):80-1. PubMed ID: 10274374
    [No Abstract]   [Full Text] [Related]  

  • 12. Perspectives. Wall Street verbatim: wider networks need not drive new cost explosion.
    Cunningham R
    Med Health; 1998 Jun; 52(25):suppl 1-4. PubMed ID: 10180838
    [No Abstract]   [Full Text] [Related]  

  • 13. Downturn may not threaten HMOs, but can physicians weather the storm?
    Diamond F
    Manag Care; 2001 Apr; 10(4):36-42. PubMed ID: 11347498
    [No Abstract]   [Full Text] [Related]  

  • 14. Deregulation in New York State--an update.
    Florman D
    Manag Care Q; 1998; 6(2):56-8. PubMed ID: 10181706
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrated systems reassess strategies.
    Johnson DE
    Health Care Strateg Manage; 1999 Jan; 17(1):2-3. PubMed ID: 10345075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It's a seller's market. Insurers turn to managed care.
    Benko LB
    Mod Healthc; 2005 Feb; 35(6):7, 14-5. PubMed ID: 15730192
    [No Abstract]   [Full Text] [Related]  

  • 17. Can Oxford heal itself?
    Smith L
    Fortune; 1997 Dec; 136(12):238-40. PubMed ID: 10176914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fleet of innovative, new firms racing to make health care information systems obsolete.
    Egger E
    Health Care Strateg Manage; 1999 Aug; 17(8):16-7. PubMed ID: 10557791
    [No Abstract]   [Full Text] [Related]  

  • 19. Exit with caution. Fla. investigates HMOs leaving Medicare markets.
    Rauber C
    Mod Healthc; 1998 Oct; 28(42):2. PubMed ID: 10186321
    [No Abstract]   [Full Text] [Related]  

  • 20. Market forces slow healthcare costs.
    Integr Healthc Rep; 1993 Dec; ():6-7. PubMed ID: 10131611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.